EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Exploring the Therapeutic Potential of BRCA1 and BRCA2 as Targets in Canine Oncology: A Comprehensive Review of Their Role in Cancer Development and Treatment

Jayson Cagadas Pasaol iD, Agnieszka Śmieszek iD, Aleksandra Pawlak iD

International Journal of Molecular Sciences · 19.02.2025 · 26 (4) · 1768

DOI: 10.3390/ijms26041768 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.02.2025. Verfasst von Jayson Cagadas Pasaol und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, Norwida 31, 50-375 …. Hauptthemen laut MEDLINE: BRCA1 Protein, BRCA2 Protein, Dog Diseases, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wrocław University of Environmental and Life Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor diseases represent a significant global health challenge, impacting both humans and companion animals, notably dogs. The parallels observed in the pathophysiology of cancer between humans and dogs underscore the importance of advancing comparative oncology and translational research methodologies. Furthermore, dogs serve as valuable models for human cancer research due to shared environments, genetics, and treatment responses. In particular, breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2), which are critical in human cancer, also influence the development and progression of canine tumors. The role of BRCA1 and BRCA2 in canine cancers remains underexplored, but its potential significance as therapeutic targets is strongly considered. This systematic review aims to broaden the discussion of BRCA1 and BRCA2 beyond mammary tumors, exploring their implications in various canine cancers. By emphasizing the shared genetic underpinnings between species and advocating for a comparative approach, the review indicates the potential of BRCA genes as targets for innovative cancer therapies in dogs, contributing to advances in human and veterinary oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinBRCA2 ProteinDog DiseasesNeoplasmsAnimalsDogsHumans

Stichwörter der Autor:innen

BRCA genesPARP inhibitorscanine cancercomparative oncologygenomic stability

Substanzen

BRCA1 ProteinBRCA2 Protein

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, Norwida 31, 50-375 Wrocław, Poland.

ORCID-Profile: Jayson Cagadas Pasaol, Agnieszka Śmieszek, Aleksandra Pawlak

Förderung

  • Wrocław University of Environmental and Life Sciences

Zitieren

APA

Pasaol, J. C., Śmieszek, A., & Pawlak, A. (2025). Exploring the Therapeutic Potential of BRCA1 and BRCA2 as Targets in Canine Oncology: A Comprehensive Review of Their Role in Cancer Development and Treatment. International Journal of Molecular Sciences, 26(4), 1768. https://doi.org/10.3390/ijms26041768

Vancouver

Pasaol JC, Śmieszek A, Pawlak A. Exploring the Therapeutic Potential of BRCA1 and BRCA2 as Targets in Canine Oncology: A Comprehensive Review of Their Role in Cancer Development and Treatment. International Journal of Molecular Sciences. 2025;26(4):1768. doi:10.3390/ijms26041768

BibTeX
@article{Pasaol2025,
  author = {Pasaol, Jayson Cagadas and Śmieszek, Agnieszka and Pawlak, Aleksandra},
  title = {Exploring the Therapeutic Potential of BRCA1 and BRCA2 as Targets in Canine Oncology: A Comprehensive Review of Their Role in Cancer Development and Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {1768},
  doi = {10.3390/ijms26041768}
}
Kostenlos starten →